title: Transcriptional regulation of the c-Myc promoter by NFAT1 involves negative and positive NFAT-responsive elements.
abstract: A number of physiological processes in both normal and cancer cells are regulated by the proto-oncogene c-Myc. Among them, processes such as cell cycle regulation, apoptosis, angiogenesis and metastasis are also controlled by the nuclear factor of activated T cells (NFAT) family of transcription factors. It is already known that NFAT upregulates c-Myc expression by binding to an element located in the minimal c-Myc promoter. However, the importance of other NFAT sites in the context of the full promoter has not been evaluated. In this work, we demonstrate that the regulation of c-Myc by NFAT1 is more complex than previously conceived. In addition to the proximal site, NFAT1 directly binds to distal sites in the c-Myc promoter with different affinities. Promoter deletions and site-directed mutagenesis of NFAT binding sites in HEK293T cells suggest that in NFAT1-mediated transactivation, some NFAT elements are negative and dominant and others are positive and recessive. Furthermore, we demonstrate that cooperation with partner proteins, such as p300, enhances NFAT1-mediated transactivation of the c-Myc promoter. At last, the newly identified sites are also responsive to NFAT2 in HEK293T cells. However, in NIH3T3 cells, the regulation mediated by NFAT proteins is not dependent on the known NFAT sites, including the site previously described. Thus, our data suggest that the contribution of NFAT to the regulation of c-Myc expression may depend on a balance between the binding to positive and negative NFAT-responsive elements and cooperation with transcriptional cofactors, which may differ according to the context and/or cell type.
authors.affiliation: Program of Cellular Biology, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil.
authors.forename: Giuliana P
authors.initials: GP
authors.lastname: Mognol
authors.forename: Patricia S
authors.initials: PS
authors.lastname: de Araujo-Souza
authors.forename: Bruno K
authors.initials: BK
authors.lastname: Robbs
authors.forename: Leonardo K
authors.initials: LK
authors.lastname: Teixeira
authors.forename: Joao P B
authors.initials: JP
authors.lastname: Viola
mesh_terms: D000818:Animals; D001665:Binding Sites; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D019703:Calcineurin / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D057809:HEK293 Cells; D006801:Humans; D051379:Mice; D008810:Mice, Inbred C57BL; D016297:Mutagenesis, Site-Directed; D050778:NFATC Transcription Factors / Q000737:chemistry / Q000378:metabolism*; D041681:NIH 3T3 Cells; D011401:Promoter Regions, Genetic; D017434:Protein Structure, Tertiary; D000090063:Proto-Oncogene Mas; D016271:Proto-Oncogene Proteins c-myc / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D014158:Transcription, Genetic; D050880:p300-CBP Transcription Factors / Q000378:metabolism
chemical_list: C000715470:MAS1 protein, human; D050778:NFATC Transcription Factors; D000090063:Proto-Oncogene Mas; D016271:Proto-Oncogene Proteins c-myc; D050880:p300-CBP Transcription Factors; D019703:Calcineurin; D002118:Calcium